These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8554981)

  • 1. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender.
    Heagerty A; Smith A; English J; Lear J; Perkins W; Bowers B; Jones P; Gilford J; Alldersea J; Fryer A; Strange RC
    Br J Cancer; 1996 Jan; 73(1):44-8. PubMed ID: 8554981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma.
    Yengi L; Inskip A; Gilford J; Alldersea J; Bailey L; Smith A; Lear JT; Heagerty AH; Bowers B; Hand P; Hayes JD; Jones PW; Strange RC; Fryer AA
    Cancer Res; 1996 May; 56(9):1974-7. PubMed ID: 8616834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking.
    Warwick A; Sarhanis P; Redman C; Pemble S; Taylor JB; Ketterer B; Jones P; Alldersea J; Gilford J; Yengi L
    Carcinogenesis; 1994 Dec; 15(12):2841-5. PubMed ID: 8001244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual.
    Lear JT; Heagerty AH; Smith A; Bowers B; Payne CR; Smith CA; Jones PW; Gilford J; Yengi L; Alldersea J; Fryer AA; Strange RC
    Carcinogenesis; 1996 Sep; 17(9):1891-6. PubMed ID: 8824510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype.
    Ramachandran S; Lear JT; Ramsay H; Smith AG; Bowers B; Hutchinson PE; Jones PW; Fryer AA; Strange RC
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):61-7. PubMed ID: 9950241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 CYP2D6 EM and glutathione s-transferase GSTM1 null genotypes and cigarette smoking.
    Warwick AP; Redman CW; Jones PW; Fryer AA; Gilford J; Alldersea J; Strange RC
    Br J Cancer; 1994 Oct; 70(4):704-8. PubMed ID: 7917923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, ras and gsp.
    Perrett CW; Clayton RN; Pistorello M; Boscaro M; Scanarini M; Bates AS; Buckley N; Jones P; Fryer AA; Gilford J
    Carcinogenesis; 1995 Jul; 16(7):1643-5. PubMed ID: 7614700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction.
    Lear JT; Smith AG; Bowers B; Heagearty AH; Jones PW; Gilford J; Alldersea J; Strange RC; Fryer AA
    J Invest Dermatol; 1997 Apr; 108(4):519-22. PubMed ID: 9077484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci.
    Clairmont A; Sies H; Ramachandran S; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
    Carcinogenesis; 1999 Jul; 20(7):1235-40. PubMed ID: 10383895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression.
    Sarhanis P; Redman C; Perrett C; Brannigan K; Clayton RN; Hand P; Musgrove C; Suarez V; Jones P; Fryer AA; Farrell WE; Strange RC
    Br J Cancer; 1996 Dec; 74(11):1757-61. PubMed ID: 8956789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype.
    Ramachandran S; Fryer AA; Smith AG; Lear JT; Bowers B; Hartland AJ; Whiteside JR; Jones PW; Strange RC
    Pharmacogenetics; 2001 Apr; 11(3):247-54. PubMed ID: 11337940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours.
    Ramachandran S; Hoban PR; Ichii-Jones F; Pleasants L; Ali-Osman F; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
    Pharmacogenetics; 2000 Aug; 10(6):545-56. PubMed ID: 10975609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci.
    Elexpuru-Camiruaga J; Buxton N; Kandula V; Dias PS; Campbell D; McIntosh J; Broome J; Jones P; Inskip A; Alldersea J
    Cancer Res; 1995 Oct; 55(19):4237-9. PubMed ID: 7671227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial results of glutathione-S-transferase GSTM1 and GSTT1 genotypes and genetic predisposition for laryngeal carcinoma].
    Jahnke V; Strange R; Matthias C; Fryer AA
    Laryngorhinootologie; 1995 Nov; 74(11):691-4. PubMed ID: 8561822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours.
    Heagerty AH; Fitzgerald D; Smith A; Bowers B; Jones P; Fryer AA; Zhao L; Alldersea J; Strange RC
    Lancet; 1994 Jan; 343(8892):266-8. PubMed ID: 7905099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma.
    Lear JT; Smith AG; Heagerty AH; Bowers B; Jones PW; Gilford J; Alldersea J; Strange RC; Fryer AA
    Carcinogenesis; 1997 Aug; 18(8):1499-503. PubMed ID: 9276622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients.
    Lira MG; Provezza L; Malerba G; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Alaibac M; Turco A; Girolomoni G; Tessari G
    Exp Dermatol; 2006 Dec; 15(12):958-65. PubMed ID: 17083362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 2D6 and glutathione S-transferase genotype in sudden infant death syndrome.
    Chen CL; Liu Q; Evans WE; Sander CH; Relling MV
    J Paediatr Child Health; 1997 Feb; 33(1):31-7. PubMed ID: 9069041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma.
    Jahnke V; Strange R; Matthias C; Fryer A
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S147-9. PubMed ID: 9065651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.